跳至主要内容
临床试验/NCT01841827
NCT01841827已完成不适用

The Headache Inducing Effects of Cilostazol on Migraine Patients

Danish Headache Center1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
1
主要终点
The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.

研究概览

简要总结

We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with migraine without aura according to the IHS criteria from
  • Healthy besides migraine

排除标准

  • Tension-type headache more than 3 days per month
  • Other types of primary headaches
  • Pregnancy
  • History of vascular diseases or psychiatric diseases.

研究组 & 干预措施

Cilostazol

Active Comparator

Capsule of Cilostazol 200 mg are taken orally on each study day

干预措施: Cilostazol (Drug)

Placebo

Placebo Comparator

A capsule of placebo containing starch are taken orally on each study day.

干预措施: Placebo (Drug)

结局指标

主要结局

The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.

时间窗: Outcome measure will be done within 3 month. Final data will be presented within 6 months

Rectruitment of 14 patients will be done during April and May. Experiments will be carried out in May and June. Each experiment day takes 1½ hour. Data analysis will be done in June and July. Final data will be presented within 6 months.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Song Guo

MD

Danish Headache Center

研究点 (1)

Loading locations...

相似试验